Ghana's National Vaccine Institute — government agency coordinating local vaccine manufacturing initiatives and pre-qualifying manufacturers for continental market access.
Chief Executive Officer of the National Vaccine Institute (NVI), Dr Sodzi Sodzi-Tettey, has disclosed that Ghana is preparing to pre-qualify Ghanaian companies to manufacture vaccines for the local and wider African market. …
… The National Vaccine Institute (NVI) says the mechanism could help address one of the major constraints facing local manufacturers: the limited size of Ghana’s domestic market. …
… The pilot, led in Ghana by the National Vaccine Institute (NVI), is intended to help institutions identify strengths and capacity gaps in the systems needed to support ethical, efficient and scientifically rigorous clinical research. …
… The grants were presented at a Research Meets Manufacturing award ceremony in Accra on 19 August, co-hosted by the National Vaccine Institute (NVI) and the German development agency GIZ. …
… t burden on the country’s health financing system and could affect the availability and affordability of medicines for patients. “Something very important happened in my office two days ago,” President Mahama said, explaining that representatives of the National Vaccine Institute …
… He said the plan had been presented to him by the National Vaccine Institute, the Ministry of Health, the Pharmaceutical Association of Ghana and other allied institutions. …
… He said the plan had been presented to him by the National Vaccine Institute, the Ministry of Health, the Pharmaceutical Association of Ghana and other allied institutions. …
The CEO of Ghana's National Vaccine Institute said the country is preparing to pre-qualify Ghanaian companies to manufacture vaccines for local and wider African markets, following Ghana's decision to join the Africa Pool Procurement Mechanism. A regional meeting is planned for November in Accra to launch an application process for assessing and pre-qualifying eligible companies.
The CEO of Ghana's National Vaccine Institute said the country is preparing to pre-qualify Ghanaian companies to manufacture vaccines for local and wider African markets, following Ghana's decision to join the Africa Pool Procurement Mechanism. A regional meeting is planned for November in Accra to launch an application process for assessing and pre-qualifying eligible companies.
Ghana has signed a Memorandum of Understanding on August 21, 2026, to participate in the African Pooled Procurement Mechanism, giving Ghanaian pharmaceutical and vaccine manufacturers access to a larger continental market and creating more predictable demand for locally manufactured health products.
Ghana has signed a Memorandum of Understanding with the Africa Centres for Disease Control and Prevention to join the African Pooled Procurement Mechanism, granting Ghanaian vaccine and pharmaceutical manufacturers access to a market of about 1.4 billion people across all 55 African Union member states.
Ghana has been selected as one of eight countries worldwide to pilot a WHO benchmarking tool designed to assess and strengthen institutional capacity for conducting high-quality clinical trials. The tool examines seven functional areas across 32 objectives and 112 outcomes, and 13 Ghanaian institutions participated in an assessment exercise.
Eight Ghanaian research institutions and pharmaceutical companies have been awarded €2 million in grants under the PharmaVax Ghana programme to develop vaccines, medicines, and health products. The projects, jointly funded by Germany and the EU and implemented by GIZ, cover innovations in malaria treatment, monoclonal antibodies, diagnostics, and herbal remedies for various conditions.
Eight research partnerships have been awarded €2m in grants under the PharmaVax Ghana programme to develop new vaccines and medicines, including child-friendly malaria medicines, plant-based therapies, and AI-assisted antibody discovery for malaria and Mpox. The programme, funded by Germany and the EU, will also provide technical assistance to help researchers commercialise health products for local and regional markets.
President Mahama announced a five-year strategic plan to strengthen pharmaceutical manufacturing and reduce Ghana's reliance on imported medicines, with the goal of achieving self-sufficiency in essential drug production and positioning Ghana as a regional supply hub. The plan aims to address Ghana's current dependence on imports for approximately 70 percent of medicines used in the country.
President Mahama announced plans to expand Ghana's pharmaceutical manufacturing capacity with a five-year government plan aimed at reducing dependence on imported medicines, which currently account for about 70 per cent of medicines used in Ghana. The expansion is intended to reduce medicine costs, strengthen the provision of treatment under the Free Primary Health Care programme, and create export opportunities to neighbouring countries.
President Mahama announced a five-year plan to expand Ghana's pharmaceutical manufacturing capacity and reduce reliance on imported medicines, which currently account for 70 per cent of drugs used in the country. The plan, presented by the National Vaccine Institute, Ministry of Health, and Pharmaceutical Association of Ghana, aims to lower medicine costs and enable export to neighbouring countries.
The University of Health and Allied Sciences plans to establish an AI Centre of Excellence focused on research, innovation and capacity building in healthcare. The centre will conduct research on clinical trials, drug development, sustainable health financing and health leadership, and will train health professionals and students from tertiary institutions.
Deputy Minister of Health Professor Grace Ayensu-Danquah called on African countries to increase domestic health financing as external donor support becomes less certain, noting that official development assistance and long-standing funding models are changing and programmes many health systems have relied on can no longer be taken for granted.
President Mahama has announced that the University of Health and Allied Sciences is set to house one of West Africa's largest laboratory complexes upon completion of an ongoing laboratory block project, which is now more than 70 percent complete and will boost medical education, research, and vaccine development in Ghana.
President Mahama announced that UHAS is on course to house one of the largest laboratory complexes in West Africa upon completion of an ongoing laboratory block project that is now more than 70 percent complete. The facility is expected to boost medical education, research, and vaccine development in Ghana and strengthen the university's international standing.
President John Dramani Mahama has inaugurated a newly completed laboratory complex at the University of Health and Allied Sciences, describing it as a strategic investment that will strengthen Ghana's scientific research ecosystem and advance vaccine development, disease surveillance, and health innovation capabilities.
President Mahama has opened a newly completed laboratory complex at the University of Health and Allied Sciences, which he says will strengthen Ghana's scientific research ecosystem and advance vaccine development, disease surveillance, and health innovation.
Many Ghanaians have welcomed government plans to establish local vaccine manufacturing through the National Vaccine Institute, with respondents expressing support for the move as a way to strengthen health security, improve vaccine access, and reduce import dependence. Respondents cited confidence in Ghana's health professionals and called for regulatory bodies to maintain quality standards.
Local leaders in Ghana's Northern Region have expressed support for the country's plan to locally manufacture vaccines through a proposed National Vaccine Institute, while raising concerns over quality assurance, public trust, and equitable access to vaccination services. They say the initiative could strengthen Ghana's health security and reduce dependence on imported vaccines if properly implemented, but emphasize that success depends on strict quality control, professional training, and proper storage systems.
Local leaders in Ghana's Northern Region have expressed support for the government's plan to locally manufacture vaccines through a proposed National Vaccine Institute, citing potential to strengthen health security and reduce imported vaccine dependence, but they have raised concerns over quality assurance, public trust, and equitable access to vaccination services.
Ghana's National Vaccine Institute is seeking partnerships with investors including Ghana Exim Bank, Afreximbank, and the International Finance Corporation to fund local vaccine manufacturers, as GAVI funding ends in 2030 and Ghana will need to fund vaccines locally at about $50 million in four years. The NVI has signed a tech transfer agreement with PT Biopharma of Indonesia for tetanus-diphtheria vaccine manufacturing locally by 2027.
A nationwide survey by the National Vaccine Institute found that only 14.3 per cent of Ghanaians are aware of plans to begin local vaccine production in 2027, highlighting the need for intensified public education despite high general confidence in vaccines. The survey of 13,905 valid responses across all 16 regions and 55 districts revealed regional disparities, with rural communities in northern Ghana showing stronger vaccine acceptance than urbanised regions like Greater Accra and Ashanti.
A government official recounts his first year working under President John Mahama, highlighting the President's grasp of public sector processes and the swift implementation of solutions, and noting that Mahama's Accra Reset Agenda has gained attention in the global health community.
The Youth Impact Parliament has announced plans for a multi-million cedi chamber and office complex to deepen democratic practice and train young parliamentarians. The facility, announced at the organisation's 5th anniversary celebration, will serve as a centre of excellence for political and civic education and host a YIP Parliamentary Training Institute following its commissioning.